Interestingly, two recent gene expression profiling studies revealed that the expression levels of MORC2 are up-regulated in breast cancer tissues as compared with adjacent normal breast tissues [14] and are associated with recurrence risk of patients with highly aggressive triple-negative breast cancer [15]. Here, MORC2 is linked to breast carcinoma.